Literature DB >> 8602606

Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.

D M Menke1, M Tiemann, J K Camoriano, S F Chang, A Madan, M Chow, T M Habermann, R Parwaresch.   

Abstract

Castleman's disease (CD) is characterized by lymph node enlargement due to hyperplasia of abnormal lymphoid follicles and paracortical lymphocytic hyaline vascular (HV) stroma or plasmacytosis (PC). The lymphoid follicles in CD show involuted germinal centers and prominent mantle zone lymphocytes. Ninety-seven cases clinically suspected to be CD were analyzed according to conventional histologic criteria established by Castleman and Keller for diagnosis. Twenty-two cases were excluded as nonspecific hyperplasia (12); Hodgkin's and non-Hodgkin's lymphoma (9); and multiple myeloma involving lymph node paracortex (1). The 75 remaining cases, consisting of 51 cases of CD and 24 with altered follicles or paracortex suggestive of CD, were further analyzed immunohistologically for changes in follicular dendritic reticulum cells (FDRC) using the monoclonal antibody Ki-M4p, for germinal center proliferation with Ki-S5, for mantle zone immunophenotype with Ki-B3 and Ki-B5, for paracortical plasmacytoid monocytes with Ki-M1p, and for plasma cell clonality by applying antibodies to kappa and lambda immunoglobulin light chains. Lymph nodes showing nonspecific follicular and paracortical hyperplasia were included as controls. Hyaline vascular CD and plasma cell CD showed enlarged, polyploid FDRC with prominent nucleoli, decreased germinal center proliferation, and mantle zone populations of immunophenotypically aberrant, Ki-B3-negative B lymphocytes. Thirty-seven percent of hyaline vascular CD and plasma cell CD contained plasmacytoid monocytes, and 15% showed interstitial areas of lambda predominant plasma cells. Plasmacytoid monocytes were common in hyaline vascular CD but rare in plasma cell CD. Cases suspected to be CD that demonstrated a mantle zone population of Ki-B3-negative B lymphocytes had clinical finding of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal paraprotein, and skin changes or sclerotic bone lesions) syndrome and were reclassified as hyaline vascular CD, plasma cell CD, and mantle zone CD with an aberrant mantle zone immunophenotype only (lacking follicular center and paracortical histologic or immunohistologic abnormalities). Immunohistochemistry was valuable for identification of dysplastic FDRC, decreased germinal center proliferation, and plasmacytoid monocytes. In addition, immunohistochemistry was essential for detection of plasma cell clonality, an aberrant mantle zone immunophenotype, and mantle-zone-restricted CD that was devoid of diagnostic alterations of germinal center or paracortex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602606     DOI: 10.1093/ajcp/105.3.268

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  Presentation and Outcome of Castleman's Disease in Immunocompetent Hosts.

Authors:  Gaurav Prakash; Amanjeet Bal; Pankaj Malhotra; Vaishali Aggarwal; Alka Khadwal; Vikas Suri; Sanjay Jain; Savita Kumari; Radhika Srinivasan; Ashim Das; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-01       Impact factor: 0.900

Review 3.  HIV-associated multicentric Castleman disease.

Authors:  Deepa Reddy; Ronald Mitsuyasu
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

4.  POEMS syndrome complicated by ischaemic stroke and cerebral vasculitis.

Authors:  Leonid Vasilevskiy; Hossein Akhondi; Ann Wierman
Journal:  BMJ Case Rep       Date:  2019-07-12

5.  Targeting the mTOR pathway in idiopathic multicentric Castleman disease.

Authors:  Robert M Stern; Nancy Berliner
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

Review 6.  POEMS Syndrome: an Enigma.

Authors:  Rahma Warsame; Uday Yanamandra; Prashant Kapoor
Journal:  Curr Hematol Malig Rep       Date:  2017-04       Impact factor: 4.213

7.  [Analysis of the clinicopathologic features as well as diagnosis and treatment of 59 patients with Castleman disease].

Authors:  J Wang; L J Liang; Y M Wang; Z Y Mei; Y Z Liu; L N Liu; B J Fang; Y P Song
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

8.  Historical and pathological overview of Castleman disease.

Authors:  Midori Filiz Nishimura; Yoshito Nishimura; Asami Nishikori; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

9.  Castleman disease.

Authors:  Ibrahiem Saeed-Abdul-Rahman; Ali M Al-Amri
Journal:  Korean J Hematol       Date:  2012-09-25

10.  Isolated pulmonary manifestation of IgG4 disease with response to steroids and relapse: A rare case report.

Authors:  Ranjit Kumar Singh; Thomas Jesudason Barney Isaac; Balamugesh Thangakunam; Nittin Mathews; Anila Korula
Journal:  Lung India       Date:  2015 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.